Catatonia as a risk factor for the development of neuroleptic malignant syndrome: Report of a case following treatment with clozapine-Reference-Cited by-同舟云学术

Catatonia as a risk factor for the development of neuroleptic malignant syndrome: Report of a case following treatment with clozapine

Published:2009-01 Issue:1 Volume:10 Page:70-73
ISSN:1562-2975
Container-title:The World Journal of Biological Psychiatry
language:en
Short-container-title:The World Journal of Biological Psychiatry

Author:

Paparrigopoulos Thomas,Tzavellas Elias,Ferentinos Panagiotis,Mourikis Iraklis,Liappas John

Publisher

Informa UK Limited

Subject

Biological Psychiatry,Psychiatry and Mental health

Link

http://www.tandfonline.com/doi/pdf/10.1080/15622970701287369

Reference49 articles.

1. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders (DSM-IV-TR), 4th ed. Text revision. Washington, DC: American Psychiatric Association.

2. Side Effects of Atypical Antipsychotic Drugs

3. Neuroleptic Malignant Syndrome: Diagnostic Issues

4. Residual Catatonic State Following Neuroleptic Malignant Syndrome

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroleptic malignant syndrome presenting without hyperthermia: A case report of an atypical presentation;Archives of Biological Psychiatry;2024-07-06

2. The retrospective and observational study of catatonia – Diagnosis, course of illness, and the response to lorazepam – in a tertiary health-care center;Journal of Neurosciences in Rural Practice;2023-02-23

3. Molecular and cellular mechanisms leading to catatonia: an integrative approach from clinical and preclinical evidence;Frontiers in Molecular Neuroscience;2022-09-29

4. Catatonia in autism spectrum disorders: A systematic review and meta-analysis;European Psychiatry;2021-12-15

5. Malignant Catatonia Versus Neuroleptic Malignant Syndrome;Cureus;2021-06-21